keep generics off the market are already costing consumers and taxpayers $3.5 billion a year in higher drug prices," said FTC Chairman Jon Leibowitz. The deals usually follow a threatened court fight after a generic drug maker plans to bring out a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to US FTC: drug patent kickback deals up by 60 pct
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account